BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//HKU TEC - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://tec.hku.hk
X-WR-CALDESC:Events for HKU TEC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230605T080000
DTEND;TZID=UTC:20231114T170000
DTSTAMP:20241218T194030Z
CREATED:20230604T214512Z
LAST-MODIFIED:20241218T194030Z
UID:8218-1685952000-1699981200@tec.hku.hk
SUMMARY:Healthcare Innovation Challenge
DESCRIPTION:Healthcare Innovation Challenge\n\nJune 5\, 2023
URL:https://tec.hku.hk/event/healthcare-innovation-challenge-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231101T080000
DTEND;TZID=UTC:20231101T170000
DTSTAMP:20241114T000459Z
CREATED:20231031T235931Z
LAST-MODIFIED:20241114T000459Z
UID:8134-1698825600-1698858000@tec.hku.hk
SUMMARY:Collaborative Innovation Forum 2023: Funding Disruptive Tech
DESCRIPTION:  \n\n/\n\nRegister Now\n\n/\n\n\n\nOrganiser\nHKU Collaborative Innovation Centre (HKU CIC) & HKU Techno-Entrepreneurship Core (HKU TEC) \nProgramme\n\n\n\nDate:\n1 November 2023 (Wed)\n\n\nTime:\n9:15am – 1:30pm (registration starts at 9:00am)\n\n\nVenue:\nTam Wing Fan Innovation Wing Two\, G/F Run Run Shaw Building [Map]\n\n\nProgramme:\nKeynote: Bridging Research to Impact: BICI Funding Models and Case studies \nDr. Xinjian Zhou\, Co-President of Beijing Institute of Collaborative Innovation (BICI) and President of BICI USA\, Director of BICI London\n\n\n\nSection 1: RAISe+: Driving Research Commercialisation (HK$10~100million grant)  \nMr. Pierre Wang\, Assistant Director (Business Development)\, HKU Technology Transfer Office\n\n\n\nSection 2: \nFunding Opportunities for Disruptive Research (~RMB10million grant)  \nDr. Duoxiang Wang\, President of Beijing Institute of Collaborative Innovation (BICI)\n\n\n\nSection 3: \nPanel Discussion: Meet the Scientist CEOs  \nFacilitator: Mr. Paul Wang\, Director\, HKU Techno-Entrepreneurship Core \nPanellists: Dr. Junqi Wang\, Founder and CEO\, ChromX Health; Ms. Li Li\, Senior Investment Manager\, BASF Venture Capital; Dr. Xinjian Zhou\, Co-President of Beijing Institute of Collaborative Innovation (BICI)\n\n\n\nNote: Sections 2 and 3 will be conducted in Chinese; a light lunch will be provided. \n\n\n\n\n/\nParticipants\nHKU Staff and Students \nLanguage\nEnglish \nDress Code\nSmart Causal \n  \n\nSpeakers\n  \n \nDr. Duoxiang Wang \nPresident of Beijing Institute of Collaborative Innovation (BICI)\, Ph.D. supervisor at the College of Engineering\, Peking University\, and Director of Jingjinji National Center of Technology Innovation and the Research Center for China’s Industry-University-Research Integration and Innovation System. \n  \nPreviously held positions as Chairman of Xiamen PKU Taipu Technology\, Vice Dean of the College of Engineering at Peking University\, and Vice President of Southern University of Science and Technology. \n\n\n  \n  \n\n\n \nDr. Xinjian Zhou \nCo-President of Beijing Institute of Collaborative Innovation (BICI) and President of BICI USA\, Director of BICI London. \n  \nDr. Zhou received his B.S. and Ph.D. in Physics from Peking University and Cornell University\, respectively. Before joining BICI\, Dr. Zhou has worked in product development and system engineering as Senior/Staff Engineer at ASML\, technology scouting and investment as Venture Manager at Technology-To-Business (TTB) center of Siemens\, and technology transfer as BD director at Xerox Palo Alto Research Center (PARC). \n\n\n  \n  \n  \n\n\n \nDr. Junqi Wang \nFounder and CEO\, ChromX Health \n  \nDr. Wang is one of the global leaders in the field of micro gas chromatography technology. He participated in the founding and commercialization of Targeted Compound Monitoring\, LLC and Kindwell Inc in US\, and led the Kindwell Inc team to develop the company’s core technologies and products in the role of CTO. Incubated by BICI\, ChromX Health is a high-tech company focused on developing revolutionary and innovative technologies to fully decode the metabolic molecular information in human breath. ChromX Health integrates Micro-Electro-Mechanical Systems (MEMS) and Artificial Intelligence (AI) in the analysis of biomarkers in breathomics for disease screening\, diagnosis\, and precision medicine. \n  \n \nMs. Li Li \nInvestment Director\, BASF Venture Capital \nMs. Li graduated from Fudan University majoring in Economics. Joining BASF Venture Capital in 2018\, she is responsible for venture capital and invested company management in China. Her investment career began in the China M&A consulting department of PwC; she later joined Voith China andestablished China’s M&A and corporate strategy department\, focusing on researching opportunities inAsia’s rail transit\, energy\, paper and other manufacturing industries; Ms. Li also served in the venturecapital department of Saudi Basic Industries Corporation and promoted the completion of the team’s first venture capital investment in China. BASF is an important foreign investment enterprise in China’s chemical industry. It has invested more than 6 billion euros in Greater China to date (more than 9 billion euros jointly invested with partners). \n\n\n  \n  \n\n\n \nProfessor Liu Pengtao \nSchool of Biomedical Sciences\, The University of Hong Kong \nProfessor Liu is currently a professor at the School of Biomedical Sciences\, The University of Hong Kong. He graduated from Henan Normal University with a Bachelor of Science (B.S.) in biology\, and obtained his Master of Sciences from Chinese Academy of Sciences and Institute of Genetics. Pengtao Liu received a Ph.D. from Baylor College of Medicine (Houston\, Texas\, USA). Dr. Liu did his postdoc training at National Cancer Institute (Maryland\, USA). Prior to joining The University of Hong Kong\, Pengtao Liu was a Senior Group Leader and an affiliated faculty member at the Wellcome Trust-MRC Stem Cell Institute\, University of Cambridge. Wellcome Trust\, the EU and NIH funded researches in Liu lab.
URL:https://tec.hku.hk/event/collaborative-innovation-forum-2023-funding-disruptive-tech/
ATTACH;FMTTYPE=image/png:https://tec.hku.hk/wp-content/uploads/2023/11/652779d737cf9-980x401-1-1.png
END:VEVENT
END:VCALENDAR